Latest PEG ratio for Iradimed: -521.34 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-521.34
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
Iradimed (IRMD) currently reports a PEG ratio of -521.34. That is below the Healthcare sector average of 11.64. Use the charts on this page to explore Iradimed's PEG ratio history and peer comparisons.
Iradimed's PEG ratio of -521.34 is lower than the Healthcare sector average of 11.64. That is roughly 4578.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The PEG ratio is a valuation multiple that relates Iradimed's market price to a fundamental measure such as earnings, sales, or book value. At -521.34, IRMD can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current PEG ratio of -521.34, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 11.64. From there, open related valuation or income-statement pages for Iradimed, and consider following IRMD for alerts when major investors trade the stock.
Iradimed is classified in the Healthcare sector. On PEG ratio, it currently shows -521.34 versus a sector average near 11.64. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IRMD with unrelated industries.